Atlas

Form 483

Abbott Laboratories Form 483, 2009-04-01

FDA issued a Form 483 to Abbott Laboratories on 2009-04-01 with 2 public-safe observations.

483· Form 483 issued2 observations

Abbott Laboratories · Columbus, United States · Issued April 1, 2009

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

1 Apr 2009
21 CFR 106.100(k)

Complaint procedures

Cited by Phillip M Pontikos, Leslie R Clark

1 Apr 2009
21 CFR 106.100(k)(2)

Complaints - investigation

Cited by Phillip M Pontikos, Leslie R Clark

Inspected site

ALAbbott LaboratoriesColumbus, United States

Inspection team

PMPhillip M Pontikos
LRLeslie R Clark

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 106.100(k)Cited across public-safe Form 483 observations1x
21 CFR 106.100(k)(2)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Book a demoStart a free trial

Full 483 report

Get the verbatim text of all 2 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere